HUP0202229A2 - Orális folyékony gyógyszerkészítmények, amelyek kinolonszármazékokat és ízelfedőként ioncserélő gyantákat tartalmaznak - Google Patents

Orális folyékony gyógyszerkészítmények, amelyek kinolonszármazékokat és ízelfedőként ioncserélő gyantákat tartalmaznak

Info

Publication number
HUP0202229A2
HUP0202229A2 HU0202229A HUP0202229A HUP0202229A2 HU P0202229 A2 HUP0202229 A2 HU P0202229A2 HU 0202229 A HU0202229 A HU 0202229A HU P0202229 A HUP0202229 A HU P0202229A HU P0202229 A2 HUP0202229 A2 HU P0202229A2
Authority
HU
Hungary
Prior art keywords
oral liquid
exchange resins
taste
mashing
pharmaceutical compositions
Prior art date
Application number
HU0202229A
Other languages
English (en)
Inventor
Allan Chor-Lun Fan
Rong Gao
Zezhi Jesse Shao
Daniel Charles Stewart
Leonore Catherine Witchey-Lakshmanan
Original Assignee
Schering-Plough Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering-Plough Ltd. filed Critical Schering-Plough Ltd.
Publication of HUP0202229A2 publication Critical patent/HUP0202229A2/hu
Publication of HUP0202229A3 publication Critical patent/HUP0202229A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgyát kinolonok vagy származékaik orális folyékonykészítményei képezik, amelyekben ioncserélő gyantákat, példáuldivinil-benzollal térhálósított metakrilsav polimereket alkalmaznakvivőanyagként a kinolonok rendkívül keserű ízének elfedésére. Ó
HU0202229A 1999-07-14 2000-07-12 Oral liquid pharmaceutical compositions containing quinolone derivatives and ion exchange resins as taste mashing HUP0202229A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35354999A 1999-07-14 1999-07-14

Publications (2)

Publication Number Publication Date
HUP0202229A2 true HUP0202229A2 (hu) 2002-11-28
HUP0202229A3 HUP0202229A3 (en) 2008-10-28

Family

ID=23389610

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202229A HUP0202229A3 (en) 1999-07-14 2000-07-12 Oral liquid pharmaceutical compositions containing quinolone derivatives and ion exchange resins as taste mashing

Country Status (24)

Country Link
EP (1) EP1200129B1 (hu)
JP (2) JP2003504416A (hu)
AR (1) AR024715A1 (hu)
AT (1) ATE411047T1 (hu)
AU (1) AU777993B2 (hu)
BG (1) BG65656B1 (hu)
BR (1) BR0012439A (hu)
CA (1) CA2378894C (hu)
CY (1) CY1108801T1 (hu)
CZ (1) CZ302919B6 (hu)
DE (1) DE60040540D1 (hu)
DK (1) DK1200129T3 (hu)
ES (1) ES2313897T3 (hu)
HU (1) HUP0202229A3 (hu)
IL (2) IL147242A0 (hu)
MX (1) MXPA02000501A (hu)
NO (1) NO20020134D0 (hu)
NZ (1) NZ516536A (hu)
PL (1) PL202027B1 (hu)
PT (1) PT1200129E (hu)
SI (1) SI1200129T1 (hu)
SK (1) SK287415B6 (hu)
WO (1) WO2001005431A1 (hu)
ZA (1) ZA200200026B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
JP5009707B2 (ja) * 2007-07-10 2012-08-22 東和薬品株式会社 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤
EA023294B1 (ru) * 2010-05-19 2016-05-31 Астеллас Фарма Инк. Фармацевтическая композиция, содержащая солифенацин

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
WO1993005816A1 (en) * 1991-09-17 1993-04-01 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
DE69419281T2 (de) * 1993-04-28 2000-03-23 Takeda Chemical Industries Ltd Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物

Also Published As

Publication number Publication date
ES2313897T3 (es) 2009-03-16
CA2378894C (en) 2005-11-22
EP1200129A1 (en) 2002-05-02
SK287415B6 (sk) 2010-09-07
ATE411047T1 (de) 2008-10-15
PT1200129E (pt) 2008-12-17
EP1200129B1 (en) 2008-10-15
HUP0202229A3 (en) 2008-10-28
CZ302919B6 (cs) 2012-01-18
IL147242A0 (en) 2002-08-14
AR024715A1 (es) 2002-10-23
BG65656B1 (bg) 2009-05-29
JP2011246497A (ja) 2011-12-08
IL147242A (en) 2008-12-29
AU777993B2 (en) 2004-11-11
CA2378894A1 (en) 2001-01-25
NO20020134L (no) 2002-01-11
BR0012439A (pt) 2002-04-02
AU5930200A (en) 2001-02-05
CY1108801T1 (el) 2012-05-23
DE60040540D1 (de) 2008-11-27
ZA200200026B (en) 2003-04-02
NO20020134D0 (no) 2002-01-11
PL202027B1 (pl) 2009-05-29
JP2003504416A (ja) 2003-02-04
NZ516536A (en) 2003-09-26
SK532002A3 (en) 2002-05-09
DK1200129T3 (da) 2009-01-12
SI1200129T1 (sl) 2009-06-30
MXPA02000501A (es) 2002-07-02
PL352183A1 (en) 2003-08-11
BG106329A (en) 2002-08-30
WO2001005431A1 (en) 2001-01-25
CZ200271A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
NO20013736L (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
DE60037020D1 (en) Anilinochinazoline als protein-tyrosin-kinasehemmer
MXPA04001114A (es) Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
BR0013277A (pt) Derivados de 3(5) ureido-pirazol, processo para sua preparação e uso dos mesmos como agentes antitumorais
GB0102687D0 (en) Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
BR0211807A (pt) Derivados ativos amino-ftalazinona como inibidores de cinase, processo para sua preparação e composições farmacêuticas para os mesmos
HUP0202490A3 (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
NO20016007L (no) Rekombinant anti-CD40-antistoff og anvendelser derav
NO20041277L (no) Farmasoytiske preparater for behandling av astma.
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
BRPI0408486A (pt) derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
HUP0105281A2 (hu) Rákellenes hatású benzaldehidszármazékok és gyógyászati alkalmazásuk
HUP0202229A2 (hu) Orális folyékony gyógyszerkészítmények, amelyek kinolonszármazékokat és ízelfedőként ioncserélő gyantákat tartalmaznak
NO991161D0 (no) TNF-<beta>-lignende protein for behandling av prostatakreft, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
NO990282L (no) Absorbsjonsforsterker
DK1590317T3 (da) Enantiomerren (4S,8S)- og (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecandisyre og dennes derivater, fremgangsmåde til disses fremstilling og anvendelse til fremstilling af farmaceutiske midler
WO2003033652A3 (en) TUMOR ENDOTHELIAL MARKER 5α MOLECULES AND USES THEREOF
EP1232748A4 (en) SUBSTITUTED NITROBENZENE-LIKE DERIVATIVE PRODUCT AS A MEDICINAL PRODUCT OR OTHER EFFICIENT PRODUCTS
AU2001282410A1 (en) N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
MXPA03010739A (es) Moleculas de marcador endotelial tumoral 7-alfa y uso de las mismas.

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal